Inclusion Criteria:  Body mass index 18.0 to 30.0 kg/m^2, inclusive Body weight ≤102 kg Willing to consume a high-fat breakfast, including pork Adheres to the contraception requirements of the protocol Additional criteria apply.  Exclusion Criteria:  Received any investigational drug or device in a clinical research study within 90 days Evidence of current severe acute respiratory syndrome (SARS-CoV-2) infection History of any drug or alcohol abuse in the past 2 years; a confirmed positive drugs of abuse test result Regular alcohol consumption; a confirmed positive alcohol breath test at screening Current smoker; a confirmed positive breath carbon monoxide reading; current user of e-cigarettes and nicotine replacement products in the last 6 months Female of childbearing potential, pregnant, or breastfeeding Male participant with pregnant or lactating partners Clinically significant abnormal clinical chemistry, hematology or urinalysis result Positive for hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (HCV Ab) or human immunodeficiency virus (HIV) Active renal and/or hepatic disease History of clinically significant cardiovascular, renal, hepatic, endocrine, metabolic, respiratory, gastrointestinal (GI), neurological or psychiatric disorder Any form of cancer in the 5 years (exceptions apply) History of adrenal insufficiency Have a condition that could be aggravated by glucocorticoid antagonism Donation or loss of greater than 400 mL of blood or plasma within the previous 3 months Currently using glucocorticoids or have a history of systemic glucocorticoid use in the last 12 months or 3 months for inhaled products Additional criteria apply.